Barclays’s Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares CLVT.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-140,500
Closed -$4.18M 5412
2024
Q1
$4.18M Buy
140,500
+4,167
+3% +$142K ﹤0.01% 1987
2023
Q4
$5.22M Hold
136,333
﹤0.01% 2050
2023
Q3
$3.99M Buy
136,333
+41,428
+44% +$1.44M ﹤0.01% 1464
2023
Q2
$3.9M Buy
94,905
+39,096
+70% +$1.47M ﹤0.01% 1484
2023
Q1
$2.29M Buy
55,809
+8,700
+18% +$392K ﹤0.01% 2094
2022
Q4
$1.78M Buy
+47,109
New +$1.98M ﹤0.01% 2339
2022
Q2
Sell
-38,697
Closed -$2.63M 5342
2022
Q1
$2.63M Buy
+38,697
New +$2.62M ﹤0.01% 1662

Barclays's CLVT.PRA Position: Q2 2024 in Review

Barclays sold out of Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares (CLVT.PRA) in Q2 2024, closing a stake of 140,500 shares — an estimated $4.18M sold.

Barclays first reported a position in CLVT.PRA in Q1 2022 and held it in 7 quarters. The position peaked at $5.22M in Q4 2023. 0 funds tracked by Wall St. Rank hold CLVT.PRA as of Q2 2024.

  • Barclays reported no remaining Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares position as of Q2 2024 after selling out during the quarter.
  • Barclays sold 140,500 Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares shares in Q2 2024, an estimated $4.18M.
  • Barclays first reported a position in Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares in Q1 2022 and held it in 7 quarters.
  • Barclays's Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares position peaked at $5.22M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares as of Q2 2024.

Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.